Efforts to improve cancer imaging technologies are crucial for diagnosing and treating the disease effectively. This transition from experimental to clinical use requires bridging the gap between ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

A team of scientists from NTU Singapore has developed a new biochip that, when paired with artificial intelligence, can ...

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a new biochip that, when paired with Artificial Intelligence (AI), can detect quickly and accurately ...

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a new biochip that, when ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

Researchers have developed a new AI system that improves lung cancer detection by analysing CT scans at both microscopic and ...

DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.

Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts, including two oral presentations, featuring data generated using its ...

Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...